Trials / Completed
CompletedNCT03546491
Evaluate Dental Plaque Benefit of a Preventive Treatment Gel
A Clinical Study to Evaluate Anti-Plaque Benefit of a Gel in a Modified- 4 Day Plaque Model
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Procter and Gamble · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to evaluate anti-plaque efficacy of a preventive treatment gel in a modified 4-day plaque model.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Preventive Gel | 0.4% Stannous Fluoride |
| DRUG | Marketed Control | 0.243% Sodium Fluoride |
Timeline
- Start date
- 2018-05-08
- Primary completion
- 2018-06-22
- Completion
- 2018-06-22
- First posted
- 2018-06-06
- Last updated
- 2019-09-04
- Results posted
- 2019-09-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03546491. Inclusion in this directory is not an endorsement.